•  
  •  
 

Author Credentials

Christopher Burrell BS Zachary Wilson DO Dominika Lozowska MD BSc

DOI

http://dx.doi.org/10.18590/mjm.2018.vol4.iss4.4

Abstract

Dynamin 2 (DMN2) mutations cause centronuclear myopathy (CNM) and Charcot Marie Tooth (CMT). Herein we discuss the details of a patient's case of adult onset CNM. We also highlight the unique features of this case with regards to the importance of electromyography (EMG), muscle biopsy and genetic testing in identifying CNM, as well as potential for improving outcomes by having a high index or suspicion and emphasizing better access to healthcare in underserved areas.

Conflict(s) of Interest

Disclaimers: The authors declare no conflict of interest.

References with DOI

1. Romero NB. Centronuclear myopathies: a widening concept. Neuromuscul Disord [Internet]. 2010;20(4):223. Available from: http://dx.doi.org/10.1016/j.nmd.2010.01.014

2. Liewluck T, Lovell TL, Bite A V., Engel AG. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation. Neuromuscul Disord [Internet]. 2010;20(12):801-4. Available from: http://dx.doi.org/10.1016/j.nmd.2010.07.273

3. Tranchant C, Dondaine N. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. 2007;17:955-9. https://doi.org/10.1016/j.nmd.2007.06.467

4. Catteruccia M, Fattori F, Codemo V, Ruggiero L, Maggi L, Tasca G, et al. Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort. Neuromuscul Disord [Internet]. 2013;23(3):229-38. Available from: http://dx.doi.org/10.1016/j.nmd.2012.12.009

5. Gal A, Inczedy-Farkas G, Pal E, Remenyi V, Bereznai B, Geller L, et al. The coexistence of dynamin 2 mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy. Clin Neuropathol [Internet]. 2014;34(2):89-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25492887

6. Bitoun M, Maugenre S, Jeannet PY, Lacène E, Ferrer X, Laforêt P, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005;37(11):1207-9. https://doi.org/10.1038/ng1657

7. Tasfaout H, Buono S, Guo S, Kretz C, Messaddeq N, Booten S, et al. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice. Nat Commun [Internet]. 2017;8:1-13. Available from: http://dx.doi.org/10.1038/ncomms15661

8. Cassandrini D, Trovato R, Rubegni A, Lenzi S, Fiorillo C, Baldacci J, et al. Congenital myopathies: Clinical phenotypes and new diagnostic tools. Ital J Pediatr. 2017;43(1):1-16. https://doi.org/10.1186/s13052-017-0419-z

9. Fattori F, Maggi L, Bruno C, Cassandrini D, Codemo V, Catteruccia M, et al. Centronuclear myopathies: genotype–phenotype correlation and frequency of defined genetic forms in an Italian cohort. J Neurol. 2015;262(7):1728-1730. https://doi.org/10.1007/s00415-015-7757-9

10. Susman RD, Quijano-Roy S, Yang N, Webster R, Clarke NF, Dowling J, et al. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. Neuromuscul Disord [Internet]. 2010;20(4):229-37. Available from: http://dx.doi.org/10.1016/j.nmd.2010.02.016

Share

COinS